U.S. markets closed

Fresenius Medical Care AG & Co. KGaA (FMS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
35.03-0.33 (-0.93%)
At close: 4:00PM EST

35.03 +0.02 (0.06%)
After hours: 4:00PM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Engulfing Line (Bullish)

Engulfing Line (Bullish)

Previous Close35.36
Open35.10
Bid35.02 x 800
Ask35.01 x 800
Day's Range34.86 - 35.45
52 Week Range29.17 - 46.55
Volume325,188
Avg. Volume407,585
Market Cap20.519B
Beta (5Y Monthly)0.98
PE Ratio (TTM)9.49
EPS (TTM)3.69
Earnings DateN/A
Forward Dividend & Yield0.72 (2.03%)
Ex-Dividend DateAug 28, 2020
1y Target Est37.57
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-16% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Benzinga

    Recap: Fresenius Medical Care Q4 Earnings

    Shares of Fresenius Medical Care (NYSE:FMS) rose 0.0% after the company reported Q4 results. Quarterly Results Earnings per share fell 50.00% year over year to $0.76, which missed the estimate of $0.77. Revenue of $5,246,000,000 higher by 2.26% from the same period last year, which missed the estimate of $6,000,000,000. Guidance Earnings guidance hasn't been issued by the company for now. Revenue guidance hasn't been issued by the company for now. How To Listen To The Conference Call Date: Feb 23, 2021 View more earnings on FMS Time: 09:30 AM ET Webcast URL: https://services.choruscall.de/DiamondPassRegistration/register?confirmationNumber=9256167&linkSecurityString=d6077a4d9 Technicals 52-week high: $46.55 Company's 52-week low was at $29.17 Price action over last quarter: down 6.85% Company Overview Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients in roughly 4,000 clinics across the globe as of December 2019. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line. See more from BenzingaClick here for options trades from BenzingaEarnings Scheduled For February 23, 2021© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Moody's

    Fresenius Medical Care Holdings, Inc. -- Moody's announces completion of a periodic review of ratings of Fresenius Medical Care Holdings, Inc.

    Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Fresenius Medical Care Holdings, Inc. Frankfurt am Main, January 19, 2021 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Fresenius Medical Care Holdings, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review discussion held on 14 January 2021 in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.